|
US4088751A
(en)
|
1972-04-07 |
1978-05-09 |
Colgate-Palmolive Company |
Self-heating cosmetic
|
|
US4171429A
(en)
|
1977-03-29 |
1979-10-16 |
Research Corporation |
Pyrimidine to pyrimidine transformation process
|
|
EP0028489B1
(en)
|
1979-11-05 |
1983-10-05 |
Beecham Group Plc |
Enzyme derivatives, and their preparation
|
|
JPS5770693A
(en)
|
1980-10-22 |
1982-05-01 |
Fuji Photo Film Co Ltd |
Desensitizing composition
|
|
EP0422011A1
(de)
|
1988-05-05 |
1991-04-17 |
BASF Aktiengesellschaft |
Mittel auf der basis von uracil-derivaten zur wachstumsförderung und fettreduktion bei tieren
|
|
KR0155168B1
(ko)
|
1989-09-29 |
1998-11-16 |
미우라 아끼라 |
6-치환된 아시클로피리미딘 뉴클레오시드 유도체 및 이를 활성성분으로 함유하는 항비루스제
|
|
JPH0699170B2
(ja)
|
1990-01-19 |
1994-12-07 |
日東紡績株式会社 |
耐火被覆材
|
|
JPH0525144A
(ja)
|
1991-04-15 |
1993-02-02 |
Nissan Chem Ind Ltd |
ウラシル誘導体及び有害生物防除剤
|
|
JPH0525142A
(ja)
|
1991-07-12 |
1993-02-02 |
Nissan Chem Ind Ltd |
ウラシル誘導体及び有害生物防除剤
|
|
JPH0543555A
(ja)
|
1991-08-13 |
1993-02-23 |
Nissan Chem Ind Ltd |
ウラシル誘導体及び有害生物防除剤
|
|
TW284688B
(es)
|
1991-11-20 |
1996-09-01 |
Takeda Pharm Industry Co Ltd |
|
|
GB2263639A
(en)
|
1992-01-28 |
1993-08-04 |
Merck & Co Inc |
Substituted pyrimidinones as neurotensin antagonists
|
|
JPH063761A
(ja)
|
1992-06-19 |
1994-01-14 |
Fuji Photo Film Co Ltd |
ハロゲン化銀写真感光材料
|
|
US6444656B1
(en)
|
1992-12-23 |
2002-09-03 |
Biochem Pharma, Inc. |
Antiviral phosphonate nucleotides
|
|
KR0151811B1
(ko)
|
1993-12-21 |
1998-10-15 |
강박광 |
신규한 항바이러스성 2,4-피리미딘디온 유도체 및 그의 제조방법
|
|
JP3781200B2
(ja)
|
1994-04-27 |
2006-05-31 |
コニカミノルタホールディングス株式会社 |
ハロゲン化銀写真感光材料の処理方法
|
|
JP3261641B2
(ja)
|
1994-04-28 |
2002-03-04 |
コニカ株式会社 |
ハロゲン化銀写真感光材料の処理方法
|
|
US5612359A
(en)
|
1994-08-26 |
1997-03-18 |
Bristol-Myers Squibb Company |
Substituted biphenyl isoxazole sulfonamides
|
|
JP3200070B2
(ja)
|
1994-11-16 |
2001-08-20 |
シナプティック・ファーマスーティカル・コーポレーション |
ジヒドロピリミジン類およびその使用
|
|
US6268369B1
(en)
|
1994-11-16 |
2001-07-31 |
Synaptic Pharmaceutical Corporation |
5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines
|
|
US6228861B1
(en)
|
1995-11-16 |
2001-05-08 |
Synaptic Pharmaceutical Corporation |
Dihydropyrimidines and uses thereof
|
|
WO1997017969A1
(en)
|
1995-11-16 |
1997-05-22 |
Synaptic Pharmaceutical Corporation |
Dihydropyrimidines and uses thereof
|
|
US5719190A
(en)
|
1996-02-28 |
1998-02-17 |
Pfizer Inc. |
Inhibition of myeloperoxidase activity
|
|
US6245773B1
(en)
|
1996-05-16 |
2001-06-12 |
Synaptic Pharmaceutical Corporation |
5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines
|
|
US6172066B1
(en)
|
1996-05-16 |
2001-01-09 |
Synaptic Pharmaceutical Corporation |
Dihydropyrimidines and uses thereof
|
|
WO1997042956A1
(en)
|
1996-05-16 |
1997-11-20 |
Synaptic Pharmaceutical Corporation |
Didhydropyrimidines and uses thereof
|
|
DE19647380A1
(de)
|
1996-11-15 |
1998-05-20 |
Hoechst Ag |
5-Ring-Heterocyclen als Inhibitoren der Leukozytenadhäsion und VLA-4-Antagonisten
|
|
US6096753A
(en)
|
1996-12-05 |
2000-08-01 |
Amgen Inc. |
Substituted pyrimidinone and pyridone compounds and methods of use
|
|
AR038955A1
(es)
|
1996-12-05 |
2005-02-02 |
Amgen Inc |
Compuestos de pirimidinona y piridona sustituidos y metodos para su uso
|
|
HUP0001140A3
(en)
|
1996-12-05 |
2002-05-28 |
Amgen Inc Thousand Oaks |
Substituted pyrimidinone and pyridone compounds and methods of use
|
|
DE69723869T2
(de)
|
1996-12-31 |
2004-04-22 |
Dr. Reddy's Laboratories Ltd. |
Heterozyklische verbindungen, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen die diese enthalten und ihre anwendung in der behandlung von diabetis und verwandten krankheiten
|
|
TW536540B
(en)
|
1997-01-30 |
2003-06-11 |
Bristol Myers Squibb Co |
Endothelin antagonists: N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide and N-(4,5-dimethyl-3-isoxazolyl)-2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl)methyl]-4'-(2-oxazolyl)[1,1'-biphe
|
|
DE19731784A1
(de)
|
1997-07-24 |
1999-02-04 |
Bayer Ag |
Substituierte N-Aryl-N-thioxocarbonyl-sulfonamide
|
|
US6211370B1
(en)
|
1998-01-13 |
2001-04-03 |
Harvard University |
Asymmetric cycloaddition reactions
|
|
US6130340A
(en)
|
1998-01-13 |
2000-10-10 |
President And Fellows Of Harvard College |
Asymmetric cycloaddition reactions
|
|
WO1999059561A2
(en)
|
1998-05-18 |
1999-11-25 |
Hensley, Kenneth, L. |
Resveratrol inhibition of myeloperoxidase
|
|
PT1094816E
(pt)
|
1998-07-06 |
2009-03-10 |
Bristol Myers Squibb Co |
Sulfonamidas bifenílicas duplamente antagonistas receptores de angiotensina e endotelina
|
|
CA2252144A1
(en)
|
1998-10-16 |
2000-04-16 |
University Of Alberta |
Dual action anticancer prodrugs
|
|
DE19918725A1
(de)
|
1999-04-24 |
2000-10-26 |
Bayer Ag |
Substituierte N-Cyano-sulfonsäureanilide
|
|
ATE256125T1
(de)
|
1999-06-02 |
2003-12-15 |
Janssen Pharmaceutica Nv |
Aminoalkyl substituierte (benzodioxane, benzofurane oder benzopyrane) derivate
|
|
IT1307786B1
(it)
|
1999-07-22 |
2001-11-19 |
Bracco Spa |
Analoghi di ceramidi, processo per la loro preparazione e loro usocome antitumorali.
|
|
JP2001131133A
(ja)
|
1999-08-23 |
2001-05-15 |
Sankyo Co Ltd |
新規ミエロペルオキシダーゼ阻害物質およびその製造方法
|
|
MY125533A
(en)
|
1999-12-06 |
2006-08-30 |
Bristol Myers Squibb Co |
Heterocyclic dihydropyrimidine compounds
|
|
GB2362101A
(en)
|
2000-05-12 |
2001-11-14 |
Astrazeneca Ab |
Treatment of chronic obstructive pulmonary disease
|
|
GB0013655D0
(en)
|
2000-06-05 |
2000-07-26 |
Prolifix Ltd |
Therapeutic compounds
|
|
JO2352B1
(en)
|
2000-06-22 |
2006-12-12 |
جانسين فارماسيوتيكا ان. في |
Compounds for the treatment of non-adaptation of the bottom of the uterus
|
|
CA2384041A1
(en)
|
2000-07-05 |
2002-01-24 |
Synaptic Pharmaceuticals Corporation |
Selective melanin concentrating hormone-1 (mch1) receptor antagonists and uses thereof
|
|
US6720324B2
(en)
|
2000-07-05 |
2004-04-13 |
Synaptic Pharmaceutical Corporation |
Selective melanin concentrating hormone-1 (MCH1) receptor antagonists and uses thereof
|
|
WO2002006389A2
(en)
|
2000-07-14 |
2002-01-24 |
Akzo Nobel N.V. |
Stabiliser system comprising hydroxyacids
|
|
DE10034803A1
(de)
|
2000-07-18 |
2002-01-31 |
Bayer Ag |
Substituierte Sulfonsäureanilide
|
|
DE10034800A1
(de)
|
2000-07-18 |
2002-01-31 |
Bayer Ag |
Substituierte Benzostickstoffheterocyclen
|
|
US6562967B2
(en)
|
2000-07-31 |
2003-05-13 |
Brandeis University |
Kinetic resolutions of chiral 2-and-3-substituted carboxylic acids
|
|
WO2002010096A1
(en)
|
2000-07-31 |
2002-02-07 |
Brandeis University |
Kinetic resolutions of chiral 2- and 3-substituted carboxylic acids
|
|
WO2003011799A1
(en)
|
2000-07-31 |
2003-02-13 |
Brandeis University |
Kinetic resolutions of chirat 3- and 3-substituted carboxylic acids
|
|
JP2004533406A
(ja)
|
2000-10-18 |
2004-11-04 |
フアーマセツト・リミテツド |
ウイルス感染症および異常細胞増殖を治療するための修飾ヌクレオシド
|
|
WO2002033128A2
(en)
|
2000-10-18 |
2002-04-25 |
Pharmasset Limited |
Multiplex quantification of nucleic acids in diseased cells
|
|
DE10108995A1
(de)
|
2001-02-23 |
2002-09-05 |
Abbott Gmbh & Co Kg |
Substituierte Pyrimidinon-Derivate als Liganden von Integrinrezeptoren
|
|
WO2002069903A2
(en)
|
2001-03-06 |
2002-09-12 |
Biocryst Pharmaceuticals, Inc. |
Nucleosides, preparation thereof and use as inhibitors of rna viral polymerases
|
|
ATE346951T1
(de)
|
2001-05-08 |
2006-12-15 |
Astrazeneca Ab |
Test zum nachweis von inhibitoren des enzyms myeloperokidase
|
|
DK3042894T1
(da)
|
2001-08-10 |
2016-11-07 |
Shionogi & Co |
Antiviralt middel
|
|
CA2462647A1
(en)
|
2001-10-03 |
2003-04-10 |
Michael S. South |
6-membered unsaturated heterocyclic compounds useful for selective inhibition of the coagulation cascade
|
|
JP2005509606A
(ja)
|
2001-10-03 |
2005-04-14 |
ファルマシア・コーポレーション |
凝血カスケードを選択的に阻害するのに有用な置換された多環式化合物のプロドラッグ
|
|
CA2462645A1
(en)
|
2001-10-03 |
2003-11-13 |
Pharmacia Corporation |
Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
|
|
BR0213092A
(pt)
|
2001-10-03 |
2004-10-19 |
Pharmacia Corp |
Compostos heterocìclicos de 6 elementos úteis para a inibição seletiva da cascata de coagulação
|
|
AU2003205536A1
(en)
|
2002-01-11 |
2003-07-24 |
Statens Serum Institut |
Anti-retroviral 5,6-disubstituted acyclopyrimidine nucleoside derivatives
|
|
NZ534582A
(en)
|
2002-02-27 |
2006-03-31 |
Pfizer Prod Inc |
ACC inhibitors
|
|
WO2003084936A2
(en)
|
2002-04-10 |
2003-10-16 |
Orchid Chemicals & Pharmaceuticals Limited |
Amino substituted pyrimidinone derivatives useful in the treatment of inflammation and immunological
|
|
AR039385A1
(es)
|
2002-04-19 |
2005-02-16 |
Astrazeneca Ab |
Derivados de tioxantina como inhibidores de la mieloperoxidasa
|
|
RU2356891C9
(ru)
|
2002-05-16 |
2010-03-27 |
Байер Кропсайенс Аг |
Производные пиридинкарбоксамида и их соли для применения в качестве инсектицида
|
|
EP1394241A1
(en)
|
2002-08-07 |
2004-03-03 |
Rohm And Haas Company |
Cyclic thioureas as additives for lubricating oils
|
|
EP1394242A3
(en)
|
2002-08-07 |
2004-04-21 |
Rohm And Haas Company |
Cyclic thioureas and their use as additives for lubricating oils
|
|
WO2004037159A2
(en)
|
2002-10-23 |
2004-05-06 |
Obetherapy Biotechnology |
Compounds, compositions and methods for modulating fat metabolism
|
|
US20050096319A1
(en)
|
2003-02-21 |
2005-05-05 |
Balzarini Jan M.R. |
Identification of compounds that inhibit replication of human immunodeficiency virus
|
|
NZ541883A
(en)
|
2003-02-21 |
2008-12-24 |
Tripep Ab |
Glycinamide derivative for inhibiting HIV replication
|
|
EP1611120A4
(en)
|
2003-04-07 |
2008-04-23 |
Cortical Pty Ltd |
NEW METHODS FOR THE TREATMENT OF INFLAMMATORY DISEASES
|
|
US7485604B2
(en)
|
2003-05-27 |
2009-02-03 |
Fujifilm Corporation |
Lubricant composition and method for using and preparing thereof
|
|
US7572581B2
(en)
|
2003-06-30 |
2009-08-11 |
Roche Molecular Systems, Inc. |
2′-terminator nucleotide-related methods and systems
|
|
US7947817B2
(en)
|
2003-06-30 |
2011-05-24 |
Roche Molecular Systems, Inc. |
Synthesis and compositions of 2'-terminator nucleotides
|
|
DE602004019815D1
(de)
|
2003-12-22 |
2009-04-16 |
Gilead Sciences Inc |
4'-substituierte carbovir- und abacavir-derivate sowie verwandte verbindungen mit hiv- und hcv-antiviraler wirkung
|
|
EA013427B1
(ru)
|
2004-03-15 |
2010-04-30 |
Такеда Фармасьютикал Компани Лимитед |
Ингибиторы дипептидилпептидазы
|
|
EP1753748B1
(en)
|
2004-05-12 |
2009-07-29 |
Pfizer Products Inc. |
Proline derivatives and their use as dipeptidyl peptidase iv inhibitors
|
|
US7745125B2
(en)
|
2004-06-28 |
2010-06-29 |
Roche Molecular Systems, Inc. |
2′-terminator related pyrophosphorolysis activated polymerization
|
|
US7928207B2
(en)
|
2004-06-28 |
2011-04-19 |
Roche Molecular Systems, Inc |
Synthesis and compositions of nucleic acids comprising 2′-terminator nucleotides
|
|
EP1616874A1
(en)
|
2004-07-14 |
2006-01-18 |
Universiteit Gent |
Mono- and bicyclic compounds with therapeutic activity and pharmaceutical compositions including them
|
|
US7485729B2
(en)
|
2004-08-12 |
2009-02-03 |
King Industries, Inc. |
Organometallic compositions and coating compositions
|
|
US20060036007A1
(en)
|
2004-08-12 |
2006-02-16 |
King Industries, Inc. |
Organometallic compositions and coating compositions
|
|
WO2006031806A2
(en)
|
2004-09-10 |
2006-03-23 |
Atherogenics, Inc. |
2-thiopyrimidinones as therapeutic agents
|
|
GB0420722D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
|
WO2006070292A2
(en)
|
2004-10-12 |
2006-07-06 |
Queen's University At Kingston |
Pyrimidine compounds as anti-ictogenic and/or anti-epileptogenic agents
|
|
SE0402591D0
(sv)
|
2004-10-25 |
2004-10-25 |
Astrazeneca Ab |
Novel use
|
|
MY140748A
(en)
|
2004-12-06 |
2010-01-15 |
Astrazeneca Ab |
Novel pyrrolo [3,2-d] pyrimidin-4-one derivatives and their use in therapy
|
|
US20060194821A1
(en)
|
2005-02-18 |
2006-08-31 |
The Brigham And Women's Hospital, Inc. |
Compounds inhibiting the aggregation of superoxide dismutase-1
|
|
EP1731911A1
(fr)
|
2005-06-07 |
2006-12-13 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Procédé utile pour la détection d'encéphalopathies
|
|
US7399786B2
(en)
|
2005-06-30 |
2008-07-15 |
Bexel Pharmaceuticals, Inc. |
Derivatives of amino acids for treatment of obesity and related disorders
|
|
EP1920073A2
(en)
|
2005-07-01 |
2008-05-14 |
Dako Denmark A/S |
Method of simultaneously visualizing multiple biological targets
|
|
ATE501277T1
(de)
|
2005-07-01 |
2011-03-15 |
Dako Denmark As |
Monomere und polymere linker zur konjugierung von biologischen molekülen und anderen stoffen
|
|
EP1948638B1
(en)
|
2005-08-12 |
2011-08-03 |
Schering Corporation |
Compounds for the treatment of inflammatory disorders
|
|
CA2630884A1
(en)
|
2005-11-30 |
2007-06-07 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of c-met and uses thereof
|
|
JP5094416B2
(ja)
|
2005-12-28 |
2012-12-12 |
武田薬品工業株式会社 |
糖尿病治療剤
|
|
DE102006000651A1
(de)
|
2006-01-03 |
2007-07-12 |
Degussa Gmbh |
Präparation aus Ionischen Flüssigkeiten und Harzen
|
|
DE102006000649A1
(de)
|
2006-01-03 |
2007-07-05 |
Degussa Gmbh |
Universell einsetzbare Zusammensetzungen
|
|
JP5025142B2
(ja)
|
2006-02-27 |
2012-09-12 |
株式会社東芝 |
モータ制御装置
|
|
JP5025144B2
(ja)
|
2006-02-28 |
2012-09-12 |
Ｊｘ日鉱日石エネルギー株式会社 |
内燃機関用潤滑油組成物
|
|
UY30267A1
(es)
|
2006-04-13 |
2007-11-30 |
Astrazeneca Ab |
Nuevos derivados de la tioxantina , composiciones farmacéuticas que los contienen, procedimientos de preparacion y aplicaciones
|
|
EP2463283B1
(en)
|
2006-04-20 |
2014-06-11 |
Pfizer Products Inc. |
Fused phenyl Amido heterocyclic compounds for the prevention and treatment of glucokinase-mediated diseases
|
|
US8771626B2
(en)
|
2006-05-31 |
2014-07-08 |
E I Du Pont De Nemours And Company |
Process for purifying perfluorinated products
|
|
WO2007142577A1
(en)
|
2006-06-05 |
2007-12-13 |
Astrazeneca Ab |
Pyrrolo[3,2-d]pyrimidin-4-one derivative as myeloperoxidase inhibitor
|
|
TW200804383A
(en)
|
2006-06-05 |
2008-01-16 |
Astrazeneca Ab |
New compounds
|
|
WO2008023249A1
(en)
|
2006-08-24 |
2008-02-28 |
Chemfit Speciality Chemicals (Pty) Ltd |
Polyvinylchloride composition
|
|
US20100055071A1
(en)
|
2006-11-21 |
2010-03-04 |
Martin Robert Leivers |
Anti-Viral Compounds
|
|
EP2097420B1
(en)
|
2006-11-29 |
2012-04-04 |
Pfizer Products Inc. |
Spiroketone inhibitors of acetyl-coa carboxylase
|
|
US20080153697A1
(en)
|
2006-12-22 |
2008-06-26 |
E. I. Dupont De Nemours And Company |
Mixtures of ammonia and ionic liquids
|
|
US7928111B2
(en)
|
2007-06-08 |
2011-04-19 |
Senomyx, Inc. |
Compounds including substituted thienopyrimidinone derivatives as ligands for modulating chemosensory receptors
|
|
US8633186B2
(en)
|
2007-06-08 |
2014-01-21 |
Senomyx Inc. |
Modulation of chemosensory receptors and ligands associated therewith
|
|
KR20100041798A
(ko)
|
2007-06-29 |
2010-04-22 |
한국화학연구원 |
신규 ｈｉｖ 역전사효소 억제제
|
|
CN101784532B
(zh)
|
2007-06-29 |
2014-10-22 |
韩国化学研究院 |
Hiv逆转录酶抑制剂
|
|
US20090036425A1
(en)
|
2007-08-02 |
2009-02-05 |
Pfizer Inc |
Substituted bicyclolactam compounds
|
|
JP5043555B2
(ja)
|
2007-08-08 |
2012-10-10 |
株式会社カネカ |
硬化性組成物
|
|
US20090053176A1
(en)
|
2007-08-23 |
2009-02-26 |
Astrazeneca Ab |
New Combination 937
|
|
US20090054468A1
(en)
|
2007-08-23 |
2009-02-26 |
Astrazeneca Ab |
New Use 938
|
|
BRPI0817897A2
(pt)
|
2007-11-02 |
2019-09-24 |
Methylgene Inc |
composto, composição, e, métodos de inibição da atividade hdac, e de tratamento de uma doença responsiva a um inibidor de atividade hdac
|
|
GB0722680D0
(en)
|
2007-11-19 |
2007-12-27 |
Topotarget As |
Therapeutic compounds and their use
|
|
JP2009167179A
(ja)
|
2007-12-21 |
2009-07-30 |
Daiichi Sankyo Co Ltd |
環状アミン化合物を含有する医薬
|
|
CN102036956A
(zh)
|
2008-03-21 |
2011-04-27 |
柯罗瑞恩制药有限公司 |
取代的吡咯烷和哌啶化合物、它们的衍生物、以及用于治疗疼痛的方法
|
|
US8236446B2
(en)
|
2008-03-26 |
2012-08-07 |
Ada Technologies, Inc. |
High performance batteries with carbon nanomaterials and ionic liquids
|
|
WO2009129120A2
(en)
|
2008-04-15 |
2009-10-22 |
Rfs Pharma, Llc |
Nucleoside derivatives for treatment of caliciviridae infections, including norovirus infections
|
|
US8277691B2
(en)
|
2008-05-05 |
2012-10-02 |
Ada Technologies, Inc. |
High performance carbon nanocomposites for ultracapacitors
|
|
WO2009144554A1
(en)
|
2008-05-28 |
2009-12-03 |
Pfizer, Inc. |
Pyrazolospiroketone acetyl-c0a carboxylase inhibitors
|
|
CA2724603A1
(en)
|
2008-05-28 |
2009-12-03 |
Pfizer Inc. |
Pyrazolospiroketone acetyl-coa carboxylase inhibitors
|
|
EP2318370A1
(en)
|
2008-07-29 |
2011-05-11 |
Pfizer Inc. |
Fluorinated heteroaryls
|
|
MX2011002166A
(es)
|
2008-08-28 |
2011-04-07 |
Pfizer |
Derivados de dioxa-biciclo[3.2.1]octano-2,3,1-triol.
|
|
GB0818063D0
(en)
|
2008-10-02 |
2008-11-05 |
Univ Dundee |
Compounds
|
|
JP5206367B2
(ja)
|
2008-11-27 |
2013-06-12 |
コニカミノルタエムジー株式会社 |
ウレア化合物を含む有機圧電材料
|
|
TW201038580A
(en)
|
2009-02-02 |
2010-11-01 |
Pfizer |
4-amino-5-oxo-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-6(5H)-yl)phenyl derivatives
|
|
EP2406230A1
(en)
|
2009-03-11 |
2012-01-18 |
Pfizer Inc. |
Substituted indazole amides and their use as glucokinase activators
|
|
ES2427279T3
(es)
|
2009-03-11 |
2013-10-29 |
Pfizer Inc. |
Derivados de benzofuranilo usados como inhibidores de glucocinasa
|
|
WO2010106457A2
(en)
|
2009-03-20 |
2010-09-23 |
Pfizer Inc. |
3-oxa-7-azabicyclo[3.3.1]nonanes
|
|
US20120129818A1
(en)
|
2009-04-23 |
2012-05-24 |
Desikan Rajagopal |
Compositions and Methods for Treatment of Cardiovascular Disease
|
|
US20100272783A1
(en)
|
2009-04-24 |
2010-10-28 |
Novabay Pharmaceuticals, Inc. |
Methods of Treating Infections of the Nail
|
|
JP2012526096A
(ja)
|
2009-05-08 |
2012-10-25 |
ファイザー・インク |
Ｇｐｒ１１９調節因子
|
|
JP2012526097A
(ja)
|
2009-05-08 |
2012-10-25 |
ファイザー・インク |
Ｇｐｒ１１９調節因子
|
|
US20120122948A1
(en)
|
2009-05-27 |
2012-05-17 |
Universite Libre De Beuxelles |
3-alkyl-5-fluoroindole derivatives as myeloperoxidase inhibitors
|
|
WO2010138901A1
(en)
|
2009-05-29 |
2010-12-02 |
Biogen Idec Ma Inc |
Carboxylic acid-containing compounds, derivatives thereof, and related methods of use
|
|
KR20120061063A
(ko)
|
2009-06-05 |
2012-06-12 |
화이자 인코포레이티드 |
Ｇｐｒ 119 조절제로서의 ｌ-(피페리딘-4-일)-피라졸 유도체
|
|
CA2937222C
(en)
|
2009-06-25 |
2019-06-04 |
Alkermes Pharma Ireland Limited |
Prodrugs of nh-acidic compounds
|
|
ES3031438T3
(en)
|
2009-06-25 |
2025-07-08 |
Alkermes Pharma Ireland Ltd |
Heterocyclic compounds for the treatment of neurological and psychological disorders
|
|
US9790252B2
(en)
|
2009-07-01 |
2017-10-17 |
Cornell University |
2-fluorinated riboses and arabinoses and methods of use and synthesis
|
|
WO2011005611A1
(en)
|
2009-07-09 |
2011-01-13 |
Merck Sharp & Dohme Corp. |
Neuromedin u receptor agonists and uses thereof
|
|
DE102009037300A1
(de)
|
2009-08-14 |
2011-02-17 |
Merck Patent Gmbh |
Tetracyanoborate als Schmierstoffe
|
|
EP2501696B1
(en)
|
2009-10-15 |
2016-12-28 |
Guerbet |
Imaging agents and their use for the diagnostic in vivo of neurodegenerative diseases, notably alzheimer's disease and derivative diseases
|
|
WO2011057220A2
(en)
|
2009-11-09 |
2011-05-12 |
Northwestern University |
Compositions and methods for treating lymphoma
|
|
FR2953145B1
(fr)
|
2009-11-30 |
2013-07-19 |
Inst Francais Du Petrole |
Solution absorbante contenant un inhibiteur de degradation derive de la pyrimidine ou de la triazine et procede d'absorption de composes acides contenus dans un effluent gazeux
|
|
WO2011094890A1
(en)
|
2010-02-02 |
2011-08-11 |
Argusina Inc. |
Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators
|
|
WO2011097607A1
(en)
|
2010-02-08 |
2011-08-11 |
Southern Research Institute |
Anti-viral treatment and assay to screen for anti-viral agent
|
|
US8513230B2
(en)
|
2010-03-05 |
2013-08-20 |
Karyopharm Therapeutics, Inc. |
Nuclear transport modulators and uses thereof
|
|
WO2011163594A2
(en)
|
2010-06-24 |
2011-12-29 |
Alkermes, Inc. |
Prodrugs of nh-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives
|
|
WO2012016133A2
(en)
|
2010-07-29 |
2012-02-02 |
President And Fellows Of Harvard College |
Ros1 kinase inhibitors for the treatment of glioblastoma and other p53-deficient cancers
|
|
ES2352926B1
(es)
|
2010-12-07 |
2012-01-12 |
Universidad De Granada |
Fenucil deuterado y derivados, procedimiento para su preparación y usos de los mismos.
|
|
GEP201706656B
(en)
|
2011-11-11 |
2017-04-25 |
Pfizer |
2-thiopyrimidinones
|
|
JP6003761B2
(ja)
|
2013-03-27 |
2016-10-05 |
富士ゼロックス株式会社 |
送風管、送風装置及び画像形成装置
|
|
US8884314B1
(en)
|
2013-05-10 |
2014-11-11 |
Osram Sylvania Inc. |
Circuitry configurable based on device orientation
|